Related Experiment Video
Updated: Apr 23, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
PICALM modulates autophagy activity and tau accumulation
Kevin Moreau1, Angeleen Fleming2, Sara Imarisio3
1Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.
Abstract:
Genome-wide association studies have identified several loci associated with Alzheimer's disease (AD), including proteins involved in endocytic trafficking such as PICALM/CALM (phosphatidylinositol binding clathrin assembly protein). It is unclear how these loci may contribute to AD pathology. Here we show that CALM modulates autophagy and alters clearance of tau, a protein which is a known autophagy substrate and which is causatively linked to AD, both in vitro and in vivo. Furthermore, altered CALM expression exacerbates tau-mediated toxicity in zebrafish transgenic models. CALM influences autophagy by regulating the endocytosis of SNAREs, such as VAMP2, VAMP3 and VAMP8, which have diverse effects on different stages of the autophagy pathway, from autophagosome formation to autophagosome degradation. This study suggests that the AD genetic risk factor CALM modulates autophagy, and this may affect disease in a number of ways including modulation of tau turnover.
Insights
Phosphatidylinositol binding clathrin assembly protein (CALM) influences Alzheimer's disease (AD) pathology by modulating autophagy and tau protein clearance. CALM
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Genome-wide association studies link Alzheimer's disease (AD) risk loci to endocytic trafficking proteins like PICALM/CALM.
- The precise mechanisms by which these genetic factors contribute to AD pathogenesis remain largely unknown.
Purpose of the Study:
- To investigate the role of CALM in modulating autophagy and tau protein clearance in Alzheimer's disease.
- To elucidate how CALM influences cellular processes relevant to AD pathology.
Main Methods:
- In vitro and in vivo experiments to assess CALM's effect on autophagy.
- Utilized zebrafish transgenic models to study CALM's impact on tau-mediated toxicity.
- Examined CALM's regulation of SNARE proteins involved in endocytosis and autophagy.
Main Results:
- CALM was found to modulate autophagy and alter the clearance of tau protein, a key player in AD.
- Altered CALM expression in zebrafish models exacerbated tau-related neurotoxicity.
- CALM regulates the endocytosis of SNAREs, impacting autophagosome formation and degradation.
Conclusions:
- The Alzheimer's disease genetic risk factor CALM plays a significant role in modulating autophagy.
- CALM's influence on tau turnover and autophagy presents a potential therapeutic target for Alzheimer's disease.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Cellular Injury V: Apoptosis and Autophagy

